- Home
- ICUCW vs SIGA Comparison
ICUCW vs SIGA Comparison
Compare ICUCW & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICUCW | SIGA |
|---|---|---|
| Founded | N/A | 1995 |
| Country | United States | United States |
| Employees | 18 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 341.0M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ICUCW | SIGA |
|---|---|---|
| Price | $0.02 | $4.61 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 68.1K | ★ 554.3K |
| Earning Date | N/A | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.32 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $224.81 |
| P/E Ratio | ★ N/A | $14.47 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $4.29 |
| 52 Week High | $0.08 | $9.62 |
Technical Indicators
Market Signals| Indicator | ICUCW | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 34.33 | 43.66 |
| Support Level | $0.01 | $4.29 |
| Resistance Level | $0.03 | $4.80 |
| Average True Range (ATR) | 0.00 | 0.14 |
| MACD | -0.00 | 0.05 |
| Stochastic Oscillator | 14.41 | 61.36 |
Price Performance
Historical ComparisonAbout ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.